VLA-1601

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameVLA-1601

Drug Alias NameZika virus vaccine (Valneva )ZIKV-VLA-1601VLA-1601

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsZika Virus Infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesValneva Austria Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesValneva Austria Gmbh

Inactive CompaniesEmergent Biosolutions Inc

Active IndicationsZika Virus Infection

Inactive IndicationsN/A

Other Information

ATC CodeN/A